Stakeholders’ views of UK nurse and pharmacist supplementary prescribing
- 1 October 2008
- journal article
- research article
- Published by SAGE Publications in Journal of Health Services Research & Policy
- Vol. 13 (4) , 215-221
Abstract
Objectives: Supplementary prescribing (SP) by pharmacists and nurses in the UK represents a unique approach to improving patients’ access to medicines and better utilizing health care professionals’ skills. Study aims were to explore the views of stakeholders involved in SP policy, training and practice, focusing upon issues such as SP benefits, facilitators, challenges, safety and costs, thereby informing future practice and policy. Method: Qualitative, semi-structured interviews were conducted with 43 purposively sampled UK stakeholders, including pharmacist and nurse supplementary prescribers, doctors, patient groups representatives, academics and policy developers. Analysis of transcribed interviews was undertaken using a process of constant comparison and framework analysis, with coding of emergent themes. Results: Stakeholders generally viewed SP positively and perceived benefits in terms of improved access to medicines and fewer delays, along with a range of facilitators and barriers to the implementation of this form of non-medical prescribing. Stakeholders’ views on the economic impact of SP varied, but safety concerns were not considered significant. Future challenges and implications for policy included SP being potentially superseded by independent nurse and pharmacist prescribing, and the need to improve awareness of SP. Several potential tensions emerged including nurses’ versus pharmacists’ existing skills and training needs, supplementary versus independent prescribing, SP theory versus practice and prescribers versus non-prescribing peers. Conclusion: SP appeared to be broadly welcomed by stakeholders and was perceived to offer patient benefits. Several years after its introduction in the UK, stakeholders still perceived several implementation barriers and challenges and these, together with various tensions identified, might affect the success of supplementary and other forms of non-medical prescribing.Keywords
This publication has 8 references indexed in Scilit:
- Nonmedical Prescribing in the United KingdomJournal of Ambulatory Care Management, 2008
- Nurse and pharmacist supplementary prescribing in the UK—A thematic review of the literatureHealth Policy, 2008
- Supplementary prescribing by community and primary care pharmacists: an analysis of PACT data, 2004-2006Journal of Clinical Pharmacy and Therapeutics, 2008
- Nurse independent prescribing and nurse supplementary prescribing practice: national surveyJournal of Advanced Nursing, 2008
- Independent extended and supplementary nurse prescribing practice in the UK: A national questionnaire surveyInternational Journal of Nursing Studies, 2007
- Developing nurse prescribing in the UKBMJ, 2007
- Benefits and challenges of prescribing training and implementation: perceptions and early experiences of RPSGB prescribersInternational Journal of Pharmacy Practice, 2007
- Nurse-prescribing in the UK: right but also wrongThe Lancet, 2002